In 2007, the British-born professor with Hong Kong family roots moved to Singapore from London to pursue her various passions as a doctor, surgeon, and research scientist.
An outspoken proponent of technology and innovation, particularly in med tech, she was the Executive Director of the National Health Innovation Centre (NHIC) from 2017 until the end of last year.
Reflecting on her tenure at NHIC, which supports innovation and enterprise activities from the public healthcare sector in Singapore, she says, “In 2017, things were just beginning in terms of commercialising homegrown innovations and health tech products. And towards the end of my term, we were looking at implementing some of these initiatives that we have funded earlier on.“
For instance, last October, the NHIC launched the Clinical Innovation and Adoption Initiative to disburse up to $1 million to assist successful applicants in developing and distributing their technologies across the island.
Currently, only about 30 per cent of health tech innovations are widely adopted in a clinical setting, which is important as these innovations help strengthen Singapore’s defence against future healthcare challenges.
BIXEPS by Quantum TX, a device that helps with sports injuries and orthopaedic surgery rehabilitation, was one of the successful projects launched. Currently, it can be found at Alexandra Hospital and other clinical sites on the island.
I have always strived for what’s next because, as a leader, you need to think about future challenges and prepare for them. My modus operandi has always been to leave a place better than when I arrived.